Skip to Main Content

Paper Details

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
Clin Infect Dis
24
2023
CCP, COVID-19, Coronavirus Disease, Coronavirus disease 2019, IC, Immunocompromised, Patients, SARS, SARS-CoV-2, immunocompromised, infectious diseases, patients, severe, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies
Author NameAffiliation
Evan M BlochJohns Hopkins University School of Medicine
Shmuel ShohamJohns Hopkins University School of Medicine
Jonathon W SenefeldMayo Clinic
Aaron A R TobianJohns Hopkins University School of Medicine
Claudia S CohnUniversity of Minnesota
Justin E JuskewitchMayo Clinic
Ruchika GoelSimmons Cancer Institute at SIU School of Medicine and Mississippi Valley Regional Blood Center
Brenda J GrossmanWashington University School of Medicine
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Michael J JoynerMayo Clinic
Liise-Anne PirofskiAlbert Einstein College of Medicine
Kelly A GeboJohns Hopkins University School of Medicine
  • 1 - 13

Datasets

Release 1.2